Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders.

Clayton Olash; Derrick Matthew Buchanan; Randi Brown; Afik Faerman; Kirsten Cherian; George Lin; David Spiegel; James J. Gross; Nolan Williams

doi:10.1038/s44184-026-00185-7

Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders.

Clayton Olash, Derrick Matthew Buchanan, Randi Brown, Afik Faerman, Kirsten Cherian, George Lin, David Spiegel, James J. Gross, Nolan Williams

npj Mental Health Research January 31, 2026 DOI: 10.1038/s44184-026-00185-7 (opens in new tab)

Read Full Text

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	Qualitative study Open-label Peer reviewed
Sample size	30
Population	Male U.S. Special Operations veterans with TBI and PTSD
Intervention	Magnesium-ibogaine
Duration	Single treatment
Topics	Ibogaine
Citations	1
Key findings	Post-session narratives revealed four experiential domains—dialogic trauma re-appraisal, altered-self and mystical connectedness, emotional resolution, and embodied healing—that portray an accelerated, self-directed psychotherapeutic process.

Abstract

Magnesium-ibogaine, a formulation combining ibogaine with pre- and post-treatment magnesium, was recently found to yield rapid clinical improvements in U.S. Special Operations veterans with TBI and PTSD. Yet, its therapeutic phenomenology during such healing is unknown. We analyzed post-session narratives from 30 male veterans who, after a single open-label magnesium-ibogaine treatment, answered three open-ended questions. A constructivist grounded-theory approach identified four recurrent experiential domains: dialogic trauma re-appraisal marked by guided replay of autobiographical memories; altered-self and mystical connectedness; emotional resolution with surges of forgiveness, love, and renewed purpose; and embodied healing, a vivid sense of neural repair accompanied by cognitive clarity and somatic relief. Together, these themes portray an accelerated, self-directed psychotherapeutic process that dovetails with previously reported improvements in this same cohort, suggesting mind-body mechanisms involving rapid neuroplastic change and highlighting its potential to inform novel approaches to trauma and TBI.

Comparable studies

Other qualitative studies on ibogaine, most cited first.

Study	Year	Design	Participants
The ibogaine medical subculture. Individuals who had taken ibogaine in the global medical subculture	2008	Ethnographic study with systematic quantitative data collection	n = 3,414
A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment Patients with substance-related disorders	2017	Qualitative study	n = 22
A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification. Patients who received treatment for chronic opioid use in Mexico between 2012 and 2015	2018	Retrospective mixed-methods study	n = 73
Treating drug dependence with the aid of ibogaine: A qualitative study Patients with substance use disorders, including psychostimulant users	2017	Qualitative study
A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders Individuals who underwent ibogaine treatment for an opioid use disorder	2018	Qualitative study

Citations in the library

Cited by 3

Cites 37

and 32 more in the library